Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hemorrhage × bemiparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 2 Venous Thromboembolism 2 Neoplasms 2 Pulmonary Embolism 1 Hemorrhage 1

Interventions

Tranexamic Acid 5 Sodium Chloride 2 Saline Solution 2 bemiparin 1 Solutions 1 Proton Pump Inhibitors 1 Misoprostol 1 Lansoprazole 1 Injections, Intravenous 1 Goserelin 1 Gonadotropin-Releasing Hormone 1 Fibrin Tissue Adhesive 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed

Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡